Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11558)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 18, 2016 (publication date) through Sep 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nayagam JS, Pereira SP, Devlin J, Harrison PM, Joshi D. Controversies in the management of primary sclerosing cholangitis. World J Hepatol 2016; 8(5): 265-272 [PMID: 26925200 DOI: 10.4254/wjh.v8.i5.265] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i5/265.htm |
| Number | Citing Articles |
| 1 |
Jan Best, Stefaan Verhulst, Wing-Kin Syn, Kimberly Lagaisse, Noemi van Hul, Femke Heindryckx, Jan-Peter Sowa, Liesbeth Peeters, Hans Van Vlierberghe, Isabelle A. Leclercq, Ali Canbay, Laurent Dollé, Leo A. van Grunsven, Mirjam M Zegers. Macrophage Depletion Attenuates Extracellular Matrix Deposition and Ductular Reaction in a Mouse Model of Chronic Cholangiopathies. PLOS ONE 2016; 11(9): e0162286 doi: 10.1371/journal.pone.0162286
|
| 2 |
Eleonora Druve Tavares FAGUNDES, Alexandre Rodrigues FERREIRA, Caroline Caldeira HOSKEN, Thaís Costa Nascentes QUEIROZ. PRIMARY SCLEROSING CHOLANGITIS IN CHILDREN AND ADOLESCENTS. Arquivos de Gastroenterologia 2017; 54(4): 286 doi: 10.1590/s0004-2803.201700000-50
|
| 3 |
Elisa Pose, Pau Sancho-Bru, Mar Coll. Experimental Cholestasis Research. Methods in Molecular Biology 2019; 1981: 249 doi: 10.1007/978-1-4939-9420-5_16
|
| 4 |
Eduardo A. Rodriguez, Elizabeth J. Carey, Keith D. Lindor. Emerging treatments for primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 2017; 11(5): 451 doi: 10.1080/17474124.2017.1293524
|
| 5 |
Gerri Mortimore. Primary sclerosing cholangitis: a pre-malignant condition. Gastrointestinal Nursing 2017; 15(8): 26 doi: 10.12968/gasn.2017.15.8.26
|
| 6 |
Matei Mandea, Dragos M. Oancea, Mihaela C. Ghioca, Speranta M. Iacob, Razvan A. Iacob, Ioana. G. Lupescu, Liliana S. Gheorghe. The Significance of Enzymatic Cholestasis in Inflammatory Bowel Disease Patients for the Diagnosis of Primary Sclerosing Cholangitis—A Retrospective Study. Journal of Clinical Medicine 2025; 14(16): 5915 doi: 10.3390/jcm14165915
|
| 7 |
Massimiliano Cadamuro, Noemi Girardi, Gregory J. Gores, Mario Strazzabosco, Luca Fabris. The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00115
|
| 8 |
Jennifer L Horsley-Silva, Elizabeth J Carey, Keith D Lindor. Advances in primary sclerosing cholangitis. The Lancet Gastroenterology & Hepatology 2016; 1(1): 68 doi: 10.1016/S2468-1253(16)30010-3
|